Overview

A Study Of Efficacy And Safety Of Fesoterodine In Vulnerable Elderly Subjects With Overactive Bladder

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess the efficacy and safety of a flexible dose regimen of fesoterodine on urgency urinary incontinence (UUI) episodes in vulnerable elderly subjects with overactive bladder (OAB).
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Fesoterodine